NT5E and small cell lung carcinoma: Multiple studies have suggested that one of the target genes of the YAP/TAZ axis is CD73, suggesting the idea that induction of CD73 expression may provide a selective advantage to YAP1 expressing SCLC cells under treatment (92–94).